Ally Bridge Group (Ny) LLC Syros Pharmaceuticals, Inc. Transaction History

Ally Bridge Group (Ny) LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.02 - $3.8 $178,500 - $665,000	-175,000 Reduced 4.94%	3,364,895 $4 Million
Q4 2021 Feb 14, 2022	BUY	$3.26 - $4.66 $326,000 - $466,000	100,000 Added 2.91%	3,539,895 $11.5 Million
Q2 2021 Aug 16, 2021	BUY	$5.01 - $7.48 $1.5 Million - $2.24 Million	300,000 Added 9.55%	3,439,895 $18.7 Million
Q1 2021 May 17, 2021	BUY	$7.19 - $14.95 $3.58 Million - $7.44 Million	497,395 Added 18.82%	3,139,895 $23.5 Million
Q4 2020 Feb 16, 2021	BUY	$6.66 - $14.66 $17.6 Million - $38.7 Million	2,642,500 New	2,642,500 $28.7 Million

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $5.87M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.